|
|
6 June 2018 |
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
ANNUAL REPORT AND ACCOUNTS POSTED TO SHAREHOLDERS
NOTICE OF ANNUAL GENERAL MEETING ON 28 JUNE 2018 @ 10.30 AM
VENUE: SKY LIGHT CITY TOWER, 50 BASINGHALL STREET,
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2017 has been posted to shareholders.
This report includes the 'Annual Report of the Annual General Meeting' ('AGM') as well as the 'Notice of the 2018 AGM', which will be available later today, in electronic form, for download on the Company's website www.immupharma.org.
ImmuPharma's AGM will be held on Thursday 28 June at 10:30am at Sky Light City Tower, 50 Basinghall Street, EC2V 5DE.
-Ends-
|
|
|
|
||||||||||||||
|
For further information please contact:
|
||||||||||||||||
|
|
Bryan, Garnier & Co. (Joint Broker) +44 (0)20 7332 2500 Phil Walker, Corporate Finance Dominic Wilson, Sales
|
|
||||||||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.